1527-3350/asset/cover.gif?v=1&s=3cd983af6575c8dbfd6b47a63ffa95415ace15f8 "Hepatology")
fax: (33) 1-42161425
1527-3350/asset/olbannerleft.gif?v=1&s=4b2409f9534ed500d3c8da1940a23842e2b9932d)
1527-3350/asset/olbannerright.gif?v=1&s=141b9a8485298533c3e2016e937b0404f7d933e1)
Viral Hepatitis
You have full text access to this OnlineOpen article
Anti-hepatitis B virus efficacy of tenofovir disoproxil fumarate in HIV-infected patients†
Article first published online: 22 FEB 2006
DOI: 10.1002/hep.21055
Copyright © 2006 American Association for the Study of Liver Diseases
Additional Information
How to Cite
Benhamou, Y., Fleury, H., Trimoulet, P., Pellegrin, I., Urbinelli, R., Katlama, C., Rozenbaum, W., Le Teuff, G., Trylesinski, A. and Piketty, C. (2006), Anti-hepatitis B virus efficacy of tenofovir disoproxil fumarate in HIV-infected patients. Hepatology, 43: 548–555. doi: 10.1002/hep.21055
- †
Potential conflict of interest: Dr. Benhamou is a consultant and has received research grants from Gilead.
- ‡
fax: (33) 1-42161425
Publication History
- Issue published online: 22 FEB 2006
- Article first published online: 22 FEB 2006
- Manuscript Accepted: 2 DEC 2005
- Manuscript Received: 18 APR 2005
Funded by
- Gilead
- Abstract
- Article
- References
- Cited By
Cited in:
- CrossRef
This article has been cited by:
- 1, , , , , , , , , , , , , , , Patterns and Causes of Suboptimal Response to Tenofovir-Based Therapy in Individuals Coinfected With HIV and Hepatitis B Virus, Clinical Infectious Diseases, 2013, 56, 9, e87
- You have free access to this content2, Treatment of HBeAg positive chronic hepatitis B: interferon or nucleoside analogues, Liver International, 2013, 33,Direct Link:
- 3, , , , , , , Five-year on-treatment efficacy of lamivudine-, tenofovir- and tenofovir + emtricitabine-based HAART in HBV–HIV-coinfected patients, Journal of Viral Hepatitis, 2012, 19, 11Direct Link:
- 4, , , , , , , , , , , , , Hepatitis B Surface Antigen Declines and Clearance During Long-Term Tenofovir Therapy in Patients Coinfected With HBV and HIV, Journal of Infectious Diseases, 2012, 206, 6, 974
- 5, , , , , , , , , , , , Long-term outcome of primary non-responders to tenofovir therapy in HIV/HBV-co-infected patients: impact of HBV genotype G, Liver International, 2012, 32, 1Direct Link:
- 6, Role of molecular diagnostics in the management of viral hepatitis B, Expert Opinion on Medical Diagnostics, 2012, 6, 5, 395
- 7
- 8, , , , , , , , , , , Impact of lamivudine on HIV and hepatitis B virus-related outcomes in HIV/hepatitis B virus individuals in a randomized clinical trial of antiretroviral therapy in southern Africa, AIDS, 2011, 25, 14, 1727
- 9, , , , , , , , , , Predictors of HBeAg status and hepatitis B viraemia in HIV-infected patients with chronic hepatitis B in the HAART era in Brazil, BMC Infectious Diseases, 2011, 11, 1, 247
- 10, , , , , , Tenofovir improves the outcome in patients with spontaneous reactivation of hepatitis B presenting as acute-on-chronic liver failure , Hepatology, 2011, 53, 3Direct Link:
- 11
- 12, , Treatment of special populations with chronic hepatitis B infection, Expert Review of Gastroenterology & Hepatology, 2011, 5, 3, 323
- 13, , , , , , , , , , , , , , British HIV Association guidelines for the management of coinfection with HIV-1 and hepatitis B or C virus 2010, HIV Medicine, 2010, 11, 1Direct Link:
- 14, , , , , , , , , , , , Frequent hepatitis B virus rebound among HIV–hepatitis B virus-coinfected patients following antiretroviral therapy interruption, AIDS, 2010, 24, 6, 857
- 15, , , , , , , , , , , , , Long-term Therapy With Tenofovir Is Effective for Patients Co-Infected With Human Immunodeficiency Virus and Hepatitis B Virus, Gastroenterology, 2010, 139, 6, 1934
- 16, , New paradigms for treating hepatitis B in HIV/hepatitis B virus co-infected patients, Journal of Antimicrobial Chemotherapy, 2010, 65, 3, 379
- 17, , , Résultats des essais thérapeutiques dans l’hépatite chronique B, Antibiotiques, 2010, 12, 1, 42
- 18, , Traitements à long terme de l’hépatite chronique B chez le patient co-infecté par le VIH, Gastroentérologie Clinique et Biologique, 2010, 34, S136
- 19, , Antiretroviral therapy for treatment-naïve patients: A review of recent literature and the updated guidelines, Current Infectious Disease Reports, 2009, 11, 4, 311
- 20, , , Formulary Drug Reviews - Tenofovir Disoproxil Fumarate Tablets, Hospital Pharmacy, 2009, 44, 2, 165
- 21, Hepatitis B in HIV: Available treatment options and approach to therapy, Current Infectious Disease Reports, 2009, 11, 5, 407
- 22
- 23, , Pathobiology of HBV mutants and clinical impact for treatment monitoring, Expert Review of Anti-infective Therapy, 2009, 7, 3, 309
- 24, , , , Prevention and management of drug resistance for antihepatitis B treatment, The Lancet Infectious Diseases, 2009, 9, 4, 256
- 25, , , , , , , , Reduced glomerular filtration rate but sustained virologic response in HIV/hepatitis B co-infected individuals on long-term tenofovir, Journal of Viral Hepatitis, 2009, 16, 7Direct Link:
- 26, Side effects of long-term oral antiviral therapy for hepatitis B, Hepatology, 2009, 49, S5Direct Link:
- 27, , Society guidelines, US treatment algorithm, and NIH consensus: Similarities and differences in management of hepatitis B, Current Hepatitis Reports, 2009, 8, 4, 161
- 28, , , Tenofovir for the Treatment of Hepatitis B Virus, Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2009, 29, 10Direct Link:
- 29, , , , , , , , , , Viral dynamics of hepatitis B virus DNA in human immunodeficiency virus-1–hepatitis B virus coinfected individuals: Similar effectiveness of lamivudine, tenofovir, or combination therapy, Hepatology, 2009, 49, 4Direct Link:
- 30, , , , , , , , , , , , , A randomized trial of combination hepatitis B therapy in HIV/HBV coinfected antiretroviral naïve individuals in Thailand, Hepatology, 2008, 48, 4Direct Link:
- 31, , , , , , , A Treatment Algorithm for the Management of Chronic Hepatitis B Virus Infection in the United States: 2008 Update, Clinical Gastroenterology and Hepatology, 2008, 6, 12, 1315
- 32, Análogos de nucleósidos y nucleótidos en el tratamiento de la hepatitis crónica por el virus B, Enfermedades Infecciosas y Microbiología Clínica, 2008, 26, 32
- 33, , , , Antiviral treatment of chronic hepatitis B virus infections: the past, the present and the future, Reviews in Medical Virology, 2008, 18, 1Direct Link:
- 34, , , , , , , , Care of HIV patients with chronic hepatitis B: updated recommendations from the HIV-Hepatitis B Virus International Panel, AIDS, 2008, 22, 12, 1399
- 35, Combination therapy for chronic hepatitis B: Ready for prime time?, Journal of Hepatology, 2008, 48, 5, 687
- 36, , Current antiviral therapies for chronic hepatitis B, Hepatology Research, 2008, 38, 6Direct Link:
- 37, Current therapy for hepatitis C or D or immunodeficiency virus concurrent infection with chronic hepatitis B, Hepatology International, 2008, 2, 3, 296
- 38, , , , , , , , , , , , , , , , Early emergence of entecavir-resistant hepatitis B virus in a patient with hepatitis B virus/human immunodeficiency virus coinfection, Hepatology Research, 2008, 38, 6Direct Link:
- 39, , , , , , , , , , Efficacy and safety of entecavir for chronic HBV in HIV/HBV coinfected patients receiving lamivudine as part of antiretroviral therapy, AIDS, 2008, 22, 14, 1779
- 40, , , , , , , , Erratum to ‘The management of chronic hepatitis B in the immunocompromised patient: Recommendations from a single topic meeting’ [J. Clin. Virol. 41 (4) 2008 243–254], Journal of Clinical Virology, 2008, 42, 1, 104
- 41, , , Hepatitis B en pacientes con infección por el virus de la inmunodeficiencia humana, Enfermedades Infecciosas y Microbiología Clínica, 2008, 26, 71
- 42, Hepatitis B viruses: Reverse transcription a different way, Virus Research, 2008, 134, 1-2, 235
- 43, , , , , , , , , , Interruptions of tenofovir/emtricitabine-based antiretroviral therapy in patients with HIV/hepatitis B virus co-infection, AIDS, 2008, 22, 1, 152
- 44, , Le patient atteint d’hépatite chronique B non contrôlé, Gastroentérologie Clinique et Biologique, 2008, 32, 1, S7
- 45, , , , , , , Management of hepatitis B virus co-infection on and off antiretroviral therapy, Current HIV/AIDS Reports, 2008, 5, 2, 86
- 46, , Potency of tenofovir in chronic hepatitis B: Mono or combination therapy?, Journal of Hepatology, 2008, 48, 3, 383
- 47, , Role of tenofovir in the treatment of chronic HBV infection, Future Virology, 2008, 3, 3, 207
- 48, , , , , , Tenofovir-Based Rescue Therapy for Advanced Liver Disease in 6 Patients Coinfected with HIV and Hepatitis B Virus and Receiving Lamivudine, Clinical Infectious Diseases, 2008, 46, 3, e28
- 49, , , The implications of antiviral drugs with activity against hepatitis B virus and HIV, Current Opinion in Internal Medicine, 2008, 7, 1, 57
- 50, , , , , , , , The management of chronic hepatitis B in the immunocompromised patient: Recommendations from a single topic meeting, Journal of Clinical Virology, 2008, 41, 4, 243
- 51, , , , , Traitement de l’hépatite chronique B, Gastroentérologie Clinique et Biologique, 2008, 32, 8-9, 749
- 52, , Traitement de l’hépatite chronique B chez les patients co-infectés par le VIH, Gastroentérologie Clinique et Biologique, 2008, 32, 1, S20
- 53, , Treatment of chronic hepatitis B and the implications of viral resistance to therapy, Expert Review of Anti-infective Therapy, 2008, 6, 2, 191
- 54, , Treatment of chronic hepatitis B: Recommendations from an Italian workshop, Digestive and Liver Disease, 2008, 40, 8, 603
- 55, , , Update on management of hepatitis B before and after liver transplantation, Current Hepatitis Reports, 2008, 7, 1, 25
- 56, Acyclic nucleoside phosphonates: Past, present and future, Biochemical Pharmacology, 2007, 73, 7, 911
- 57, , Antiviral Therapy of Chronic Hepatitis B: Prevention of Drug Resistance, Clinics in Liver Disease, 2007, 11, 4, 869
- 58, , Chronic hepatitis B, Hepatology, 2007, 45, 2Direct Link:
- 59, , , , , Co-infection avec les hépatites virales, Journal Africain d’Hépato-Gastroentérologie, 2007, 1, 1, 38
- 60, , , Current and future therapies for chronic HBV-infections, Reviews in Medical Microbiology, 2007, 18, 4, 79
- 61, , , , , , , , , , , , , , Epidemiology, diagnosis and treatment of chronic hepatitis B in HIV-infected patients (EPIB 2005 STUDY), AIDS, 2007, 21, 10, 1323
- 62
- 63, Hepatitis B in the HIV-Coinfected Patient, JAIDS Journal of Acquired Immune Deficiency Syndromes, 2007, 45, Supplement 2, S57
- 64, , , , , , , , , , , , , , , , Hepatitis B virus genotypes : a retrospective survey in Southwestern France, 1999-2004, Gastroentérologie Clinique et Biologique, 2007, 31, 12, 1088
- 65
- 66, , Management of hepatitis B in patients with HBeAg-negative disease, Current Hepatitis Reports, 2007, 6, 3, 91
- 67, , New and Emerging Treatment of Chronic Hepatitis B, Clinical Gastroenterology and Hepatology, 2007, 5, 3, 285
- 68
- 69, , Prise en charge des malades coinfectés VIH-VHC et VIH-VHB, Gastroentérologie Clinique et Biologique, 2007, 31, 10, 887
- 70, , Tenofovir disoproxil fumarate for the treatment of hepatitis B virus infection: pharmacokinetics and clinical efficacy, Therapy, 2007, 4, 2, 141
- 71, The management of HIV and hepatitis B coinfection, Current Opinion in Infectious Diseases, 2007, 20, 1, 16
- 72, , , Understanding the Pathogenesis and Management of Hepatitis B/HIV and Hepatitis B/Hepatitis C Virus Coinfection, Clinics in Liver Disease, 2007, 11, 4, 917
- 73, 2007,
- 74, , , , , , , , , , , , , , , , , , Combination of tenofovir and lamivudine versus tenofovir after lamivudine failure for therapy of hepatitis B in HIV-coinfection, AIDS, 2006, 20, 15, 1951
- 75, From adefovir to Atripla™ via tenofovir, Viread™ and Truvada™, Future Virology, 2006, 1, 6, 709
- 76, , Hiv coinfection with hepatitis C and hepatitis B, Current Infectious Disease Reports, 2006, 8, 5, 409
- 77, Nucleotide HIV reverse transcriptase inhibitors: tenofovir and beyond, Current Opinion in HIV and AIDS, 2006, 1, 5, 373
- 78, Nuevos fármacos para el tratamiento de la hepatitis crónica por virus B, Gastroenterología y Hepatología, 2006, 29, 54
- 79, Perspectives et stratégies futures dans la prise en charge de la résistance aux analogues antiviraux dans le traitement de l’hépatite chronique B, Gastroentérologie Clinique et Biologique, 2006, 30, 10, 34
- 80, , , , , , , , , , , , , Randomized controlled study of tenofovir and adefovir in chronic hepatitis B virus and HIV infection: ACTG A5127, Hepatology, 2006, 44, 5Direct Link:
- 81, , Tenofovir disoproxil fumarate: Role in hepatitis B treatment, Hepatology, 2006, 44, 2Direct Link:
- 82, Traitement de l’hépatite chronique B résistant à la lamivudine chez les malades co-infectés par le VIH, Gastroentérologie Clinique et Biologique, 2006, 30, 10, 22
- 83, , Tratamiento de las hepatitis víricas (I). Tratamiento de la hepatitis crónica B, Enfermedades Infecciosas y Microbiología Clínica, 2006, 24, 7, 453
- 84, , , Hepatobiliary Manifestations of Human Immunodeficiency Virus,Direct Link: